Participate in the PAT2D study

Can personalised antioxidant treatment improve glycaemic control in people with type 2 diabetes?

There has been intense interest in the potential for antioxidant supplements, such as vitamin C and N-acetylcysteine, to improve glycaemic control in individuals with type 2 diabetes. Emerging research suggests that the effectiveness of antioxidant treatment depends on whether the antioxidant treatment applied is specifically designed to target and restore a specific deficiency. The antioxidant needs of people with type 2 diabetes appear to be highly individual and we hypothesise that adopting a personalised approach to antioxidant supplementation will improve glycaemic control in people with type 2 diabetes. This study will investigate the efficacy of personalised antioxidant supplementation for the treatment of type 2 diabetes.

Participation in this study involves attending our laboratory located in Melbourne for body composition scanning, blood sampling, and supervised exercise. Participants will be provided with antioxidant supplements and will receive their individual test results.

To be eligible for this study you must be:

• Aged between 35 and 75 years
• Have a confirmed type 2 diabetes diagnosis
• Have a current HbA1c ≥ 6.5%
• Not taking insulin 

Click here to read the Participant Information Letter and find out if you are eligible. 

For more information, please contact Sophie Broome (Sophie.Broome@acu.edu.au)

This study has been approved by the ACU Human Research Ethics Committee (2024-3636HC)